Literature DB >> 11369437

Regulation of insulin-like growth factor-I receptor gene expression by tumor necrosis factor-alpha and interferon-gamma.

M Shalita-Chesner1, J Katz, J Shemer, H Werner.   

Abstract

The insulin-like growth factor-I receptor (IGF-l-R) plays a critical role in normal and pathological growth processes. The expression of the IGF-l-R gene is regulated by various stimuli, including hormones and growth factors. We have investigated the molecular mechanisms by which two inhibitory cytokines, tumor necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma), regulate IGF-l-R gene expression. TNF-alpha and IFN-gamma reduced the proliferation rates of the osteogenic sarcoma cell line, Saos-2, and the human salivary gland cell line, HSG, in a dose- and time-dependent fashion. This effect was associated with significant reductions in the levels of IGF-l-R mRNA and protein, and with inhibition of IGF-l-R promoter activity, suggesting that TNF-alpha and IFN-gamma affect IGF-l-R gene expression at the transcriptional level. In addition, TNF-alpha significantly decreased IGF-l-R mRNA stability. Combined cytokine treatment inhibited cellular proliferation and promoter activity in an additive manner. Taken together, these results suggest that a novel potential mechanism by which TNF-alpha and IFN-gamma affect cellular proliferation involves suppression of IGF-l-R promoter activity, as well as destabilization of IGF-l-R transcripts.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11369437     DOI: 10.1016/s0303-7207(01)00484-1

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  7 in total

1.  Effects of alpha-interferon on insulin-like growth factor-I, insulin-like growth factor-II and insulin-like growth factor binding protein-3 secretion by a human lung cancer cell line in vitro.

Authors:  P Del Monte; C Laurino; M Arvigo; C Palermo; F Minuto; A Barreca
Journal:  J Endocrinol Invest       Date:  2005-05       Impact factor: 4.256

2.  RAGE expression and NF-kappaB activation attenuated by extracellular domain of RAGE in human salivary gland cell line.

Authors:  Christopher Chuong; Joseph Katz; Kaleb M Pauley; Marievic Bulosan; Seunghee Cha
Journal:  J Cell Physiol       Date:  2009-11       Impact factor: 6.384

3.  A high expression level of insulin-like growth factor I receptor is associated with increased expression of transcription factor Sp1 and regional lymph node metastasis of human gastric cancer.

Authors:  Yixing Jiang; Liwei Wang; Weida Gong; Daoyan Wei; Xiangdong Le; James Yao; Jaffer Ajani; James L Abbruzzese; Suyun Huang; Keping Xie
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

4.  Insulin-like growth factor 1 receptor and p38 mitogen-activated protein kinase signals inversely regulate signal transducer and activator of transcription 3 activity to control human dental pulp stem cell quiescence, propagation, and differentiation.

Authors:  Jerome Vandomme; Yasmine Touil; Pauline Ostyn; Cecile Olejnik; Pilar Flamenco; Raja El Machhour; Pascaline Segard; Bernadette Masselot; Yves Bailliez; Pierre Formstecher; Renata Polakowska
Journal:  Stem Cells Dev       Date:  2014-01-17       Impact factor: 3.272

Review 5.  Regulation of IGF-I function by proinflammatory cytokines: at the interface of immunology and endocrinology.

Authors:  Jason C O'Connor; Robert H McCusker; Klemen Strle; Rodney W Johnson; Robert Dantzer; Keith W Kelley
Journal:  Cell Immunol       Date:  2008-03-05       Impact factor: 4.868

6.  Increased tumor necrosis factor-α, cleaved caspase 3 levels and insulin receptor substrate-1 phosphorylation in the β₁-adrenergic receptor knockout mouse.

Authors:  Surekha Rani Panjala; Youde Jiang; Timothy S Kern; Steven A Thomas; Jena J Steinle
Journal:  Mol Vis       Date:  2011-07-06       Impact factor: 2.367

7.  Small interfering RNA targeted to IGF-IR delays tumor growth and induces proinflammatory cytokines in a mouse breast cancer model.

Authors:  Tiphanie Durfort; Mercedes Tkach; Mariya I Meschaninova; Martín A Rivas; Patricia V Elizalde; Alya G Venyaminova; Roxana Schillaci; Jean-Christophe François
Journal:  PLoS One       Date:  2012-01-03       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.